New Judge Assigned to PhRMA’s Lawsuit Challenging Arkansas’s First-of-Its-Kind 340B Nondiscrimination Law

U.S. Senior District Judge Billy Roy Wilson has been assigned to PhRMA's lawsuit challenging Arkansas’s 340B nondiscrimination act.

A new federal district judge has been assigned to Pharmaceutical Research and Manufacturers of America’s (PhRMA) lawsuit challenging Arkansas’s 340B nondiscrimination act.

PhRMA’s case, filed on Sept. 29, was initially assigned to U.S. District Judge Lee Rudofsky, a Trump appointee.

Read More »

Montana GOP Congressman Proposes a Host of New Conditions on 340B Hospitals

First-term U.S. Rep. Matt Rosendale (R-Mont.) has introduced a bill to impose a host of new conditions on hospital participation in the 340B drug discount program.

Montana’s at-large Republican U.S. congressman has introduced a bill to impose a host of new conditions on hospital participation in the 340B drug discount program.

First-term U.S. Rep. Matt Rosendale (R-Mont.) isn’t a member of the House Energy & Commerce

Read More »

340B Providers Might Insure HIV-at-Risk Patients in Response to Gilead’s PrEP Reimbursement Cuts

340B covered entities are bracing for a huge reimbursement cut due to start in January for Gilead pre-exposure prophylaxis (PrEP) medications.

340B covered entities are exploring buying health insurance for patients at risk of contracting HIV in response to a huge reimbursement cut due to start in January for Gilead pre-exposure prophylaxis (PrEP) medications.

Gilead announced in April that, effective

Read More »

Half of Congressional Black Caucus Asks CMS to End Medicare Drug Payment Cuts for 340B Hospitals

Reps. Robin Kelly (D-Ill.), left, and Lisa Blunt Rochester (D-Del.), right, led the Sept. 24 letter urging CMS to end the nearly 30% cut in Medicare Part B drug payments to 340B hospitals.

Half of the Congressional Black Caucus (CBC) has asked Centers for Medicare & Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure to end the nearly 30% cut in Medicare Part B drug payments to 340B hospitals.

Reps. Robin Kelly (D-Ill.) and Lisa

Read More »

Federal Appeals Court Hears Arguments in Case Involving Walgreens’s 340B Program

The U.S. Court of Appeals for the Fourth Circuit heard arguments in J.R. v. Walgreens Boots Alliance on Sept. 22.

A federal appeals court is considering some South Carolina Walgreens customers’ claims that Walgreens, in its capacity as a 340B contract pharmacy and as a 340B contract pharmacy third-party administrator (TPA), violated their privacy rights under South Carolina law.

The

Read More »

Final 340B Registration Period of 2021 Ends on Oct. 15

The final 340B covered entity registration period of 2021 ends on Friday, Oct. 15.

The final 340B covered entity registration period of the year began on Friday, Oct. 1 and ends on Friday, Oct. 15. Eligible hospitals, health centers, clinics, and their child sites and contract pharmacies registered during the period can begin participating

Read More »

Claims Manager Plus: Helping 340B Pharmacies Smooth Out the Bumps

SPONSORED CONTENT

Running a 340B pharmacy is a complicated business, especially considering the varying requirements from payers that can wreak havoc on your bottom line. That’s why Sentry continually works to develop new tools and services to help you stay on top of things and keep your reimbursements moving.

Claims Manager Plus (CMP) is our solution; an automated software solution that helps users adhere to payer requirements, minimize denials, and speed up processing pharmacy claims by almost any payer, or for carving in or out 340B. It’s also indispensable in helping manage complex, government-mandated reporting requirements.

Claims Manager Plus helps you correct errors on claims and adhere to other requirements by flagging items such as:

  • Missing modifiers and prices
  • Purchase validation of NDCs billed
  • Unspecified destination payer codes
  • Incorrect NDC codes
  • Drug quantity and unit of measure validation
  • NDCs not matched to HCPCS codes
  • Crossover modifiers between payers

The tool automatically modifies claims based on the configurations you establish. It flags errors and rejections and can

Read More »

Breaking News

Breaking: HRSA Tells Boehringer Ingelheim its 340B Contract Pharmacy Restrictions Are Illegal

HRSA informed Boehringer Ingelheim today that its restrictions on 340B pricing when hospitals use contract pharmacies are illegal.

A senior federal health official informed drug manufacturer Boehringer Ingelheim (BI) today its restrictions on 340B pricing when hospitals use contract pharmacies are illegal and must end immediately, or BI could face civil monetary penalties.

U.S. Health Resources and Services

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report